Small Image | NexPlasmaGen

9894

paged,page-template,page-template-blog-small-image,page-template-blog-small-image-php,page,page-id-9894,page-child,parent-pageid-1815,paged-2,page-paged-2,bridge-core-2.6.4,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-theme-ver-24.9,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,qode-wpml-enabled,wpb-js-composer js-comp-ver-6.13.0,vc_responsive

Small Image

03 Nov NexPlasmaGen’s CPJ breast cancer in vivo preclinical trials completed

Posted at 00:00h in Blog 0 Comments

0 Likes

NexPlasmaGen is proud to announce that the preclinical trials program led by Dr. Philip Wong at the Centre Hospitaller de l’Université de Montréal was successfully completed. The first stage of...

02 Jan NexPlasmaGen’s Cold Plasma Technology to Treat Breast Cancer in Preparation for Clinical Investigation

Posted at 00:00h in Blog 0 Comments

0 Likes

NexPlasmaGen Inc. is pleased to announce that its patented cold plasma technology is in preparation for clinical investigation for the treatment of breast cancer. NexPlasmaGen has recently received financial support...

01 Jul NexPlasmaGen completed an investment phase to accelerate the development of its cold plasma technology for breast cancer treatment

Posted at 00:00h in Blog 0 Comments

0 Likes

NexPlasmaGen Inc. is pleased to announce the completion of $795,000 in private and public investment from individuals, Aligo Innovation, the Quebec MEDTEQ program and the federal MITACS and CNRC-IRAP programs...

Small Image

03 Nov NexPlasmaGen’s CPJ breast cancer in vivo preclinical trials completed

02 Jan NexPlasmaGen’s Cold Plasma Technology to Treat Breast Cancer in Preparation for Clinical Investigation

01 Jul NexPlasmaGen completed an investment phase to accelerate the development of its cold plasma technology for breast cancer treatment

London, UK Offices